CONSUN PHARMAC.GR.HD -10 Capital Reinvestment Ratio
CONSUN PHARMAC.GR.HD -10 capital reinvestment ratio. CONSUN PHARMAC.GR.HD -10 (C1P) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow (€1.21 Billion) in capital expenditures (€68.48 Million). Check C1P cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of CONSUN PHARMAC.GR.HD -10 (2021–2025)
Capital reinvestment ratio of CONSUN PHARMAC.GR.HD -10 from 2021 to 2025. This chart tracks CONSUN PHARMAC.GR.HD -10's Capital Reinvestment Ratio across 5 annual periods. Also explore net asset growth rate of CONSUN PHARMAC.GR.HD -10 to track the company's year-over-year net asset growth rate.
CONSUN PHARMAC.GR.HD -10 Capital Reinvestment Ratio by Year (2021–2025)
CONSUN PHARMAC.GR.HD -10 capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see C1P operating cash flow.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | €1.21 Billion | €68.48 Million | ▼ -43.6% |
| 2024 | 0.10x | €1.09 Billion | €109.00 Million | ▲ +56.2% |
| 2023 | 0.06x | €818.97 Million | €52.56 Million | ▲ +17.9% |
| 2022 | 0.05x | €947.68 Million | €51.59 Million | ▼ -59.8% |
| 2021 | 0.14x | €725.54 Million | €98.25 Million | — |